Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?

Metabolism: Clinical and Experimental

Volumn 55, Issue 5, 2006, Pages 650-655

  Mertens, Ilse ^a   Van der Planken, Marc ^a   Corthouts, Bob ^a   Van Gaal, Luc F ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; VON WILLEBRAND FACTOR;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; ENDOTHELIUM; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; VISCERA; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; ANTIGENS; C-REACTIVE PROTEIN; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MIDDLE AGED; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES; VON WILLEBRAND FACTOR; WAIST-HIP RATIO;

EID: 33646061982     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.01.001     Document Type: Article

References (35)

1. Sowers J.R. Obesity as a cardiovascular risk factor. Am J Med 115 (2003) 37S-41S
2. Caballero A.E. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 11 (2003) 1278-1289
3. Mertens I., and Van Gaal L.F. Obesity, haemostasis and the fibrinolytic system. Obes Rev 3 (2002) 85-101
4. Mannucci P.M. von Willebrand Factor. A marker of endothelial damage?. Arterioscler Thromb Vasc Biol 18 (1998) 1359-1362
5. Lip G.Y.H., Foster W., and Blann A.D. Plasma von Willebrand factor levels and surrogates of atherosclerosis. J Thromb Haemost 3 (2005) 659-661
6. Pottinger B.E., Read R.C., Paleolog E.M., et al. von Willebrand factor is an acute phase reactant in man. Thromb Res 15 (1989) 387-394
7. Stehouwer C.D.A. Is measurement of endothelial dysfunction clinically useful?. Eur J Clin Invest 29 (1999) 459-461
8. Steinberg H.O., Chaker H., Leaming R., et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97 (1996) 2601-2610
9. Perticone F., Ceravolo R., Candigliota M., et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress. Protective effect of vitamin C. Diabetes 50 (2001) 159-165
10. Ziccardi P., Nappo F., Giugliano G., et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105 (2002) 804-809
11. Hashimoto M., Akishita M., Eto M., et al. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord 22 (1998) 477-484
12. De Pergola G., De Mitrio V., Giorgino F., et al. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution. Int J Obes Relat Metab Disord 21 (1997) 527-535
13. Blann A.D., Bushell D., Davies A., et al. von Willebrand factor, the endothelium and obesity. Int J Obes Relat Metab Disord 17 (1993) 723-725
14. De Pergola G., De Mitrio V., Sciaraffia M., et al. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. Metabolism 46 (1997) 1287-1293
15. Charles M.A., Morange P., Eschwège E., et al., on behalf of the BIGPRO study group. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects. The BIGPRO 1 study. Diabetes Care 21 (1998) 1967-1972
16. Ferri C., Desideri G., and Valenti M. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 34 (1999) 568-573
17. Targher G., Bertolini L., Scala L., et al. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med 22 (2005) 1354-1358
18. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus (1999), World Health Organization, Geneva
19. Lukaski H.C., Johnson P.E., Bolonchuk W.W., et al. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41 (1985) 810-817
20. Deurenberg P., Weststrate J.A., and Hautvast J.G.A.J. Changes in fat-free mass during weight loss measured by bioelectrical impedance and by densitometry. Am J Clin Nutr 49 (1989) 33-36
21. van der Kooy K., and Seidell J.C. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 17 (1993) 187-196
22. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
23. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
24. Foss C.H., Vestbo E., Frøland A., et al. Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects. J Intern Med 252 (2002) 155-163
25. Weyer C., Yudkin J.S., Stehouwer C.D.A., et al. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 161 (2002) 233-242
26. Jilma B., Dallinger S., Hergovich N., et al. Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules. J Clin Endocrinol Metab 85 (2000) 1748-1751
27. von Känel R., Nelesen R.A., Le D.T., et al. Decrease in the plasma von Willebrand factor concentration following glucose ingestion: the role of insulin sensitivity. Metabolism 50 (2001) 1452-1456
28. Souto J.C., Almasy L., Muñiz-Diaz E., et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplasmin time. Arterioscler Thromb Vasc Biol 20 (2000) 2024-2028
29. Steinberg H.O., and Baron A.D. Vascular function, insulin resistance and fatty acids. Diabetologia 45 (2002) 623-634
30. Frühbeck G., Gomez-Ambrosi J., Muruzabal F.J., et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280 (2001) E827-E847
31. Bhagat K., and Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96 (1997) 3042-3047
32. van der Poll T., van Deventer S.J.H., Pasterkamp G., et al. Tumor necrosis factor induces von Willebrand factor release in healthy humans. Thromb Haemost 67 (1992) 623-626
33. Yudkin J.S., Stehouwer C.D.A., Emeis J.J., et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
34. Hotamisligil G.S., Peraldi P., Budavari A., et al. IRS-1-mediated inhibition of insulin receptor tyrokinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996) 665-668
35. Bastelica D., Morange P., Berthet B., et al. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 22 (2002) 173-178